Common Stock to Trade on Split-Adjusted Basis Beginning at Opening of Market on July 10, 2017; Intended to Enable Continued Listing on the NASDAQ Capital Market TUSTIN, Calif., July 07, 2017 (GLOBE NEWSWIRE) -- Peregrine …
Peregrine Pharmaceuticals (NASDAQ: PPHM) is a small-cap biotech stock valued at only $250 million, but if its pipeline follows through on its significant potential, this predominantly clinical-stage stock could be quite the bargain at current …
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) may be on the verge of something big with its anticancer drugs. The shares soared almost 50% on Wednesday, and the stock was indicated higher in both Wednesday’s after-hours …
According to the complaint the plaintiff alleges on behalf of all persons who purchased Peregrine Pharmaceuticals …
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is a clinical-stage biopharmaceutical company that manufactures and develops monoclonal antibodies for the treatment of cancer and viral infections. It currently has one cancer agent that is …
Peregrine Pharmaceuticals (Nasdaq: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, announced that it received today a notice from The NASDAQ Stock
TMUS, MCHP, and PPHM are moving sharply in Wednesday's trading TMUS is down ... short-term options players have …
He also illustrated catalog covers for the Amarillo Fat Stock Show and was included in Jeff Dykes' "Fifty Great Western Illustrators." Mead died in 1986. The PPHM exhibition will examine Mead's early career in Amarillo through his work as …
Among the biggest winners in Monday's early trading are Peregrine Pharmaceutical (Nasdaq: PPHM) and Century Aluminum (Nasdaq ... helpful in boosting the efficacy of docetaxel, boosting the stock from $0.50 in early July to above …
If you want a Stock Review on IDRA, PIRS, PPHM or RTTR then come over to http://dailystocktracker.com/register/ and …
NBC 22mon